| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10914626 | Molecular Oncology | 2014 | 8 Pages |
Abstract
Our clinical and non-clinical data demonstrate that ALDH-1 LIs are predictive of response to therapy and further research could lead to individualized therapeutic strategies and novel therapeutic targets for EC patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
J.A. Ajani, X. Wang, S. Song, A. Suzuki, T. Taketa, K. Sudo, R. Wadhwa, W.L. Hofstetter, R. Komaki, D.M. Maru, J.H. Lee, M.S. Bhutani, B. Weston, V. Baladandayuthapani, Y. Yao, S. Honjo, A.W. Scott, H.D. Skinner, D. Berry,